Determination of naltrexone and its major metabolite, 6-β-naltrexol, in human plasma using liquid chromatography with electrochemical detection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 12, 1996, Pages 1717-1725

  Davidson, Anna F ^a   Emm, Thomas A ^a   Pieniaszek Jr , Henry J ^a  

^a DUPONT COMPANY   (United States)

Author keywords

6 naltrexol; Electrochemical detection; Human plasma; Naltrexone; Quantitative determination

Indexed keywords

DRUG METABOLITE; NALTREXOL; NALTREXONE;

ARTICLE; BLOOD ANALYSIS; DRUG DETERMINATION; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL;

EID: 0030249998     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(96)01794-3     Document Type: Article

References (17)

1. [1] J.P. Gonzalez and R.N. Brogden, Drugs, 35 (1988) 192-213.
2. [2] J.R. Volpicelli, A.L. Alterman, M. Hayashida and C.P. O'Brian, Arch. Gen. Psychiatry, 49 (1992) 876-880.
3. [3] S. O'Malley, A.J. Jaffe, G. Chang, R.S. Scottenfeld, R.E. Meyer and B. Rounsaville, Arch. Gen. Psychiatry, 49 (1992) 881-887.
4. [4] K. Verebey, J. Volavka, S.J. Mulé and R.B. Resnick, Clin. Pharmacol. Ther., 20 (1976) 315-328.
5. [5] M.C. Meyer, A.B. Straughn, M.-W. Lo, W.L. Schary and CC. Whitney, J. Clin. Psychiatry, 45 (1984) 15-19.
6. [6] M. Perez-Reyes and M.E. Wall, in R.E. Willette and G. Barnett (Eds.), Naltrexone Research Monograph No. 28, National Institute on Drug Abuse, Rockville, MD, 1980, pp. 93-101.
7. [7] G.L. Burce, H.B. Bhat and T. Sokoloski, J. Chromatogr., 137 (1977) 323-332.
8. [8] K. Verebey, M.J. Kogan, A. DePace and S.J. Mulé, J. Chromatogr., 118 (1976) 331-335.
9. [9] K. Verebey, A. DePace, D. Jukofsky, J.V. Volavka and S.J. Mulé, J. Anal. Toxicol., 4 (1980) 33-37.
10. [10] R.H. Reuning, S.B. Ashcraft and B.E. Morrison, in R.E. Willette and G. Barnett (Eds.), Naltrexone Research Monograph No. 28, National Institute on Drug Abuse, Rockville, MD, 1980, pp. 25-35.
11. [11] H. Derendorf, A. El-Koussi and E.R. Garrett, J. Pharm, Sci., 73 (1984) 621-624.
12. [12] E.F. O'Connor, S.W.T. Cheng and W.G. North, J. Chromatogr. Biomed. Appl., 491 (1989) 240-247.
13. [13] P. Zuccaro, I. Altieri, P. Betto, R. Pacifia, G. Ricciarello, L.A. Pini, E. Sternieri and S. Pichini, J. Chromatogr. Biomed. Appl., 567 (1991) 485-490.
14. [14] K.M. Monit, R.L. Foltz and D.M. Chinn, J. Anal. Toxicol., 15 (1991) 136-140.
15. [15] C.C. Nelson, M.D. Fraser, J.K. Wilfahrt and R.L. Foltz, Ther. Drug Monitr., 15 (1993) 557-562.
16. [16] H.J. Pieniaszek, Jr., A.F. Davidson, E.B. Faulkner and I.H. Benedek, J. Clin. Pharmacol., 35 (1995) 933.
17. [17] M.-W. Lo, G.P. Juergens and C.C. Whitney, Jr., Res. Commun. Chem. Pathol., 43 (1984) 159-168.